Larson Financial Group’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20K Buy
+508
New +$19.6K ﹤0.01% 2115
2026
Q1
– Sell
-22
Closed -$823 – 3712
2025
Q4
$823 Buy
+22
New +$723 ﹤0.01% 3007
2025
Q3
– Sell
-3
Closed -$95 – 3541
2025
Q2
$95 Sell
3
-1
-25% -$32 ﹤0.01% 3167
2025
Q1
$133 Hold
4
– – ﹤0.01% 2871
2024
Q4
$138 Hold
4
– – ﹤0.01% 2544
2024
Q3
$160 Hold
4
– – ﹤0.01% 2433
2024
Q2
$121 Buy
+4
New +$120 ﹤0.01% 2206

Other funds holding HRMY

Larson Financial Group's HRMY Position: Q3 2026 in Review

Larson Financial Group opened a new position in Harmony Biosciences (HRMY) in Q3 2026: 508 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #2115 among its holdings. This is a return to the name: Larson Financial Group previously reported a position in HRMY as recently as Q4 2025.

Larson Financial Group first reported a position in HRMY in Q2 2024 and has held it in 7 quarters since. 358 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • Larson Financial Group held 508 shares of Harmony Biosciences worth $20K as of Q3 2026.
  • Harmony Biosciences was a new Larson Financial Group position in Q3 2026.
  • Harmony Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2115 holding.
  • Larson Financial Group first reported a position in Harmony Biosciences in Q2 2024 and has held it in 7 quarters since.
  • 358 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.